Literature DB >> 3426303

Selective bone marrow involvement of lymphoplasmacytic cells secreting monoclonal IgA rheumatoid factor in a patient with Sjögren's syndrome and serum hyperviscosity.

C Bergonzi1, G P Merlini, S Morandi, E Bianchini, F Pavesi, V Bellotti, C M Montecucco, E Ascari.   

Abstract

The clinical features and results of serological studies of a patient with Sjögren's syndrome, IgA kappa monoclonal gammopathy, and hyperviscosity syndrome are reported. The novel aspect of this case is the selective localisation to the bone marrow of lymphoplasmacytoid cells secreting IgA kappa morphologically identical to the cells infiltrating the salivary glands. The serum of the patient contained large amounts of immunoglobulin-anti-immunoglobulin immune complexes. By gel filtration chromatography it was shown that the immune complexes formed a peak of molecular weight 680 kilodaltons. The immune complexes were dissociable under acidic conditions. The immunoglobulin with rheumatoid activity was characterised as monoclonal IgA kappa protein. Treatment with plasmapheresis combined with immunosuppressive treatment with cyclophosphamide reduced the serum viscosity with concomitant clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3426303      PMCID: PMC1003427          DOI: 10.1136/ard.46.12.938

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  Myeloma proteins (M-components) with antibody-like activity.

Authors:  M Potter
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

2.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

3.  Evidence that the malignant lymphoma of Sjögren's syndrome is a monoclonal B-cell neoplasm.

Authors:  J Zulman; R Jaffe; N Talal
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

4.  Serum hyperviscosity in Sjögren's syndrome interaction between IgG and IgG rheumatoid factor.

Authors:  D Alarcón-Segovia; E Fishbein; J L Abruzzo; R Heimer
Journal:  Ann Intern Med       Date:  1974-01       Impact factor: 25.391

Review 5.  Autoimmunity and lymphoid malignancy in New Zealand black mice.

Authors:  N Talal
Journal:  Prog Clin Immunol       Date:  1974

6.  Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor.

Authors:  M Kosaka; A Solomon
Journal:  Am J Med       Date:  1980-07       Impact factor: 4.965

7.  [Lymphoproliferative diseases and paraproteinemias in Sjogren's syndrome].

Authors:  G Bolognini; G Riva
Journal:  Schweiz Med Wochenschr       Date:  1975-11-08

8.  Deficiency of T cell mediated regulation of anti-DNA production in systemic lupus erythematosus.

Authors:  J D Clough; S A Frank; L H Calabrese
Journal:  Arthritis Rheum       Date:  1980-01

9.  Angioimmunoblastic lymphadenopathy with dysproteinaemia (AILD) and sicca syndrome.

Authors:  Y J Bignon; A Janin-Mercier; J J Dubost; J M Ristori; Y Fonck; J C Alphonse; B J Sauvezie
Journal:  Ann Rheum Dis       Date:  1986-06       Impact factor: 19.103

10.  Non-IgM monoclonal gammopathy in patients with Sjögren's syndrome.

Authors:  S Sugai; S Konda; Y Shoraski; T Murayama; T Nishikawa
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

View more
  1 in total

1.  Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands.

Authors:  H M Moutsopoulos; A G Tzioufas; M K Bai; N M Papadopoulos; C S Papadimitriou
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.